Decreased mrna expression of two FOXP3 isoforms in peripheral blood mononuclear cells from patients with rheumatoid arthritis and systemic lupus erythematosus

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 1, 2011, Pages 7-14

  Suzuki, K ^a   Setoyama, Y ^a   Yoshimoto, K ^a   Tsuzaka, K ^a   Abe, T ^a   Takeuchi, Tsutomu ^a,b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Exon 2 lacking isoform; FOXP3; Rheumatoid arthritis; Systhemic lupus erythematosus; T regulatory cell

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; ISOPROTEIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXON; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY; CD4+ T LYMPHOCYTE; DAS28; DISEASE ACTIVITY; DRUG MEGADOSE; GENE EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEDAI;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEIN ISOFORMS; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 79957823946     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400102     Document Type: Article

References (24)

1. Sakagjuchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101:455-8.
2. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus 2008; 17:421-5. (Pubitemid 351798720)
3. Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol 2008; 38:921-4.
4. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445:766-70. (Pubitemid 46279706)
5. USmith EL, Finney HM, Nesbitt AM, Ramsdell F, Robinson MK. Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology 2006; 119:203-11.
6. Mailer RK, Falk K, Rötzschke O. Absence of leucine zipper in the natural. FOXP3 Delta2 Delta7 isoform does not affect dimerization but abrogates suppressive capacity PLoS One 2009; 4:6104.
7. Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 2007; 7:305-10. (Pubitemid 46480960)
8. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, Ziegler SF, Roncarolo MG, Levings MK. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005; 115:3276-84. (Pubitemid 41567592)
9. Smith EL, Finney HM, Nesbitt AM, Ramsdell F, Robinson MK. Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation. Immunology 2006; 119:203-11. (Pubitemid 44401639)
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24. (Pubitemid 18091653)
11. Hochberg MC. The Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
12. Prevoo ML, van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:44-8.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35:630-40.
14. Van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004; 50:2775-85. (Pubitemid 39209514)
15. Cao D, Van Vollenhoven R, Klareskog L, Trollmo C, Malmström V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004; 6:335-46.
16. Miyara M, Amoura Z, Parizot C, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005; 175:8392-400. (Pubitemid 41798406)
17. Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, González-Amaro R. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006; 27:110-8. (Pubitemid 44528260)
18. Sarkar S, Fox DA. Regulatory T cell defects in rheumatoid arthritis. Arthritis Rheum 2007; 56:710-3. (Pubitemid 46399416)
19. Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol 2009; 182:1689-95.
20. Habibagahi M, Habibagahi Z, Jaberipour M, Aghdashi A. Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus. Rheumatol Int 2010.
21. Barreto M, Ferreira RC, Lourenço L, et al. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol 2009; 27:10-5.
22. Atfy M, Amr GE, Elnaggar AM, Labib HA, Esh A, Elokely AM. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus. Egypt J Immunol 2009; 16:117-26.
23. Ryder LR, Woetmann A, Madsen HO, Ødum N, Ryder LP, Bliddal H, Danneskiold-Samsøe B, Ribel-Madsen S, Bartels EM. Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis. Scand J Rheumatol 2010; 39:279-86.
24. Olivito B, Simonini G, Ciullini S, et al. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. J Rheumatol 2009; 36:2017-24.